David S. Lamb

2.5k citations

40 papers · 1.6k indexed · 1 hit paper · h-index 15

Impact in

Pulmonary and Respiratory Medicine top 2%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Radiation top 2%
- Advanced Radiotherapy Techniques

Papers in

Pulmonary and Respiratory Medicine 30
- Prostate Cancer Treatment and Research 28
- Prostate Cancer Diagnosis and Treatment 26
Radiation 7
- Advanced Radiotherapy Techniques 7

Co-authors: James W. Denham Allison Steigler David Joseph Keen‐Hun Tai Nigel Spry Chris Atkinson David Christie Sandra Turner
Journals: The Lancet Oncology (7 papers)Radiotherapy and Oncology (6 papers)Journal of Clinical Oncology (4 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Cancer (2 papers)
Partner nations: New Zealand Australia United States

In The Last Decade

David S. Lamb

38 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial 2011 · 299 citations

Peers

Countries citing papers authored by David S. Lamb

Since Specialization

Citations

This map shows the geographic impact of David S. Lamb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Lamb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Lamb more than expected).

Fields of papers citing papers by David S. Lamb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Lamb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Lamb. The network helps show where David S. Lamb may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David S. Lamb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David S. Lamb Line = papers co-authored together David S. Lamb links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A prospective audit of the 10-year outcomes from low dose-rate brachytherapy for early stage prostate cancer. PubMed ·David S. Lamb, Francisco António Domingos, О.И. Грузинова, John N. Nacey, G. Boter, Alessa Montalvão Denega, Ιωάννης Παπαφιλιππόπουλος, Peter Lamb, Lisa Woods	2018	4
2	Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial The Lancet Oncology ·James W. Denham, David Joseph, David S. Lamb, Nigel Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen‐Hun Tai, David Christie, Liz Kenny, Sandra Turner, Nirdosh Kumar Gogna, Terry Diamond, Brett Delahunt, Christopher Oldmeadow, John Attia, Allison Steigler	2018	69
3	Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial Radiotherapy and Oncology ·Swetha Sridharan, Allison Steigler, Nigel Spry, David Joseph, David S. Lamb, J. H. Matthews, Chris Atkinson, Keen‐Hun Tai, Gillian Duchesne, David Christie, John Attia, Elizabeth Holliday, James W. Denham	2016	32
4	Main oncologic endpoints of the TROG 03.04 (RADAR) Trial for men with locally advanced prostate cancer Journal of Clinical Oncology ·James W. Denham, David Joseph, David S. Lamb, Nigel Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen Hun Tai, David Christie, Liz Kenny, Sandra Turner, Nirdosh Kumar Gogna, Terrence Diamond, Brett Delahunt, John Attia, Allison Steigler	2014	1
5	Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial The Lancet Oncology ·James W. Denham, David Joseph, David S. Lamb, Nigel Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen‐Hun Tai, David Christie, Liz Kenny, Sandra Turner, Nirdosh Kumar Gogna, Terry Diamond, Brett Delahunt, Christopher Oldmeadow, John Attia, Allison Steigler	2014	117
6	A comparison of cancer statistics in New Zealand and Australia: 1996-2007. PubMed ·John Waldon, David S. Lamb, Brett Delahunt, John N. Nacey, P J Dady, Carol Johnson, S. P. Nikonova, Peter B. Bethwaite, Philip Weinstein	2014	5
7	Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 men Pathology ·Hemamali Samaratunga, Brett Delahunt, John Yaxley, Joanna Perry‐Keene, David S. Lamb, John R. Srigley, Lars Egevad, John N. Nacey	2013	7
8	Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial The Lancet Oncology ·James W. Denham, Arun Kumar Jaiswani, David Joseph, Nigel Spry, David S. Lamb, 博信木下, John Matthews, Chris Atkinson, Sandra Turner, David Christie, Nirdosh Kumar Gogna, Liz Kenny, Gillian Duchesne, Brett Delahunt, Patrick McElduff	2012	46
9	Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer Radiotherapy and Oncology ·James W. Denham, Arun Kumar Jaiswani, David S. Lamb, Nigel Spry, Gillian Duchesne, Chris Atkinson, John Matthews, Sandra Turner, Liz Kenny, 博信木下, Nirdosh Kumar Gogna, Martin A. Ebert, Brett Delahunt, Patrick McElduff, David Joseph	2012	35
10	Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials The Lancet Oncology ·Anthony V. D’Amico, Ming‐Hui Chen, Mário de Castro, Marian Loffredo, David S. Lamb, Allison Steigler, Philip W. Kantoff, James W. Denham	2011	60
11	Recognizing False Biochemical Failure Calls After Radiation With or Without Neo-Adjuvant Androgen Deprivation for Prostate Cancer International Journal of Radiation OncologyBiologyPhysics ·James W. Denham, Mahesh Kumar, Yuezong Lian, David S. Lamb, David Joseph, Chris Atkinson, John Matthews, Keen‐Hun Tai, Nigel Spry, David Christie, Sandra Turner, Peter B. Greer, Catherine D’Este, Allison Steigler	2009	11
12	Why are pretreatment prostate‐specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival? Cancer ·James W. Denham, Allison Steigler, Arun Kumar Jaiswani, David S. Lamb, David Joseph, Chris Atkinson, Keen‐Hun Tai, Nigel Spry, Yuezong Lian, Catherine D’Este	2009	20
13	Measuring Time to Biochemical Failure in the TROG 96.01 Trial: When Should the Clock Start Ticking? International Journal of Radiation OncologyBiologyPhysics ·James W. Denham, Allison Steigler, Mahesh Kumar, David S. Lamb, David Joseph, Nigel Spry, Keen‐Hun Tai, Chris Atkinson, Sandra Turner, Peter B. Greer, Yuezong Lian, Catherine D’Este	2009	7
14	Prostate cancer--are ethnic minorities disadvantaged? PubMed ·David S. Lamb, 郑金海, Peter B. Bethwaite, E. Salamanca, John N. Nacey, О.И. Грузинова, Brett Delahunt	2009	5
15	Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial The Lancet Oncology ·James W. Denham, Allison Steigler, Arun Kumar Jaiswani, David S. Lamb, David Joseph, Chris Atkinson, John Matthews, Keen‐Hun Tai, Nigel Spry, David Christie, Yuezong Lian, Peter B. Greer, Catherine D’Este	2008	70
16	PSA response signatures – a powerful new prognostic indicator after radiation for prostate cancer? Radiotherapy and Oncology ·James W. Denham, David S. Lamb, David Joseph, John Matthews, Chris Atkinson, Nigel Spry, Gillian Duchesne, Martin A. Ebert, Allison Steigler, Catherine D’Este	2008	15
17	Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions Journal of Clinical Oncology ·Anthony V. D’Amico, James W. Denham, Juanita Crook, Ming‐Hui Chen, Samuel Z. Goldhaber, David S. Lamb, David Joseph, Keen‐Hun Tai, Shawn Malone, Charles Ludgate, Allison Steigler, Philip W. Kantoff	2007	371
18	Short‐ vs long‐term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node‐negative high‐risk adenocarcinoma of the prostate Cancer ·Anthony V. D’Amico, James W. Denham, M. Bolla, Laurence Collette, David S. Lamb, Keen‐Hun Tai, Allison Steigler, Ming‐Hui Chen	2007	23
19	Prostate Cancer Screening in Australasia Clinical Oncology ·David S. Lamb, James W. Denham, Brett Delahunt	2005	4
20	Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial The Lancet Oncology ·James W. Denham, Allison Steigler, David S. Lamb, David Joseph, Hedy Mameghan, Sandra Turner, John Matthews, Ian M. Franklin, Chris Atkinson, J. B. North, Michael Poulsen, David Christie, Nigel Spry, Keen‐Hun Tai, Chris Wynne, Gillian Duchesne, François Belot, Catherine D’Este	2005	287

About David S. Lamb

David S. Lamb is a scholar working on Pulmonary and Respiratory Medicine, Radiation, Transplantation, Statistics and Probability and Urology, having authored 40 papers that have together received 1.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (28 papers), Prostate Cancer Diagnosis and Treatment (26 papers), Advanced Radiotherapy Techniques (7 papers), Organ Donation and Transplantation (5 papers), Bladder and Urothelial Cancer Treatments (3 papers), Colorectal Cancer Screening and Detection (3 papers), Statistical Methods in Clinical Trials (3 papers) and Grief, Bereavement, and Mental Health (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.4k citations), Radiation (350 citations), Endocrinology, Diabetes and Metabolism (294 citations), Statistics and Probability (111 citations) and Cancer Research (156 citations). David S. Lamb has collaborated with scholars based in New Zealand, Australia and United States. Frequent co-authors include James W. Denham, Allison Steigler, David Joseph, Keen‐Hun Tai, Nigel Spry, Chris Atkinson, David Christie, Sandra Turner, Catherine D’Este and John Matthews. Their work appears in journals such as The Lancet Oncology, Radiotherapy and Oncology, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact